Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Non Operating Interest Expenses (2016 - 2018)

Trafalgar International (GCAN) posted Non Operating Interest Expenses of $14515.0 for Q3 2018, up 554.42% on a QoQ basis from $2218.0 in Q2 2018, and up 2035.33% year-over-year from $679.75 in Q3 2017.

Analysis

Trafalgar International (GCAN) Non Operating Interest Expenses (2016 - 2018) Analysis & Trends

Trafalgar International has reported Non Operating Interest Expenses for 3 years, with the latest figure at $14515.0 in Q3 2018.

  • On a quarterly basis, Non Operating Interest Expenses rose 2035.33% year-over-year to $14515.0 in Q3 2018; TTM through Sep 2018 was $16276.0, a 5733.69% increase from a year earlier, with the FY2017 full-year figure at -$4551.0, down 51.7% from the prior year.
  • Non Operating Interest Expenses was $14515.0 for Q3 2018 at Trafalgar International, up from $2218.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $14515.0 in Q3 2018, with the low at -$2022.0 in Q4 2017.
  • Average Non Operating Interest Expenses over 3 years is $2069.4, with a median of $889.5 recorded in 2017.
  • The sharpest annual moves came in 2017 and 2018: Non Operating Interest Expenses sank 169.6% in 2017, then soared 2035.33% in 2018.
  • Over 3 years, Non Operating Interest Expenses stood at -$750.0 in 2016, then plunged by 169.6% to -$2022.0 in 2017, then surged by 817.85% to $14515.0 in 2018.
  • The last three Non Operating Interest Expenses figures came in at $14515.0 (Q3 2018), $2218.0 (Q2 2018), and $1565.0 (Q1 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 281.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 23.78 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 2.90 Mn
10 Trafalgar International 217,335.05 217,335.05 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 14,515.00
Jun 30, 2018 2,218.00
Mar 31, 2018 1,565.00
Dec 31, 2017 -2,022.00
Sep 30, 2017 -750.00
Jun 30, 2017 1,029.00
Mar 31, 2017 750.00
Dec 31, 2016 -750.00